Pharmaceutical composition and administrations thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10646481
APP PUB NO 20170087144A1
SERIAL NO

15253636

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • VERTEX PHARMACEUTICALS INCORPORATED

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Botfield, Martyn Concord, US 29 2142
Dinehart, Kirk Holliston, US 12 709
Grootenhuis, Peter D J San Diego, US 70 4748
Grossi, Alfredo Somerville, US 38 730
Hurter, Patricia Harvard, US 22 1185
Overhoff, Kirk Waltham, US 9 638
Rowe, William Medford, US 40 1943
Verwijs, Marinus Jacobus Framingham, US 31 1574
Young, Christopher Waltham, US 88 2728

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 12, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 12, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00